Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int J Neonatal Screen ; 9(3)2023 Aug 11.
Artículo en Inglés | MEDLINE | ID: mdl-37606482

RESUMEN

Dried blood spot (DBS) cards from newborn screening (NBS) programs represent a wealth of biological data. They can be stored easily for a long time, have the potential to support medical and public health research, and have secondary usages such as quality assurance and forensics, making it the ideal candidate for bio-banking. However, worldwide policies vary with regard to the duration of storage of DBS cards and how it can be used. Recent advances in genomics have also made it possible to perform extended genetic testing on DBS cards in the newborn period to diagnose both actionable and non-actionable childhood and adult diseases. Both storage and secondary uses of DBS cards raise many ethical, clinical, and social questions. The openness of the key stakeholders, namely, parents and healthcare providers (HCPs), to store the DBS cards, and for what duration and purposes, and to extended genetic testing is largely dependent on local cultural-social-specific factors. The study objective is to assess the parents' and HCPs' awareness and receptivity toward DBS retention, its secondary usage, and extended genetic testing. A cross-sectional, self-administrated survey was adopted at three hospitals, out of which two were public hospitals with maternity services, between June and December 2022. In total, 452 parents and 107 HCPs completed and returned the survey. Overall, both HCPs and parents were largely knowledgeable about the potential benefits of DBS card storage for a prolonged period and its secondary uses, and they supported extended genetic testing. Knowledge gaps were found in respondents with a lower education level who did not know that a DBS card could be stored for an extended period (p < 0.001), could support scientific research (p = 0.033), and could aid public health research, and future policy implementation (p = 0.030). Main concerns with regard to DBS card storage related to potential privacy breaches and anonymity (Parents 70%, HCPs 60%). More parents, compared to HCPs, believed that storing DBS cards for secondary research does not lead to a reciprocal benefit to the child (p < 0.005). Regarding extended genetic testing, both groups were receptive and wanted to know about actionable childhood- and adult-onset diseases. More parents (four-fifths) rather than HCPs (three-fifths) were interested in learning about a variant with unknown significance (p < 0.001). Our findings report positive support from both parents and HCPs toward the extended retention of DBS cards for secondary usage and for extended genetic testing. However, more efforts to raise awareness need to be undertaken in addition to addressing the ethical concerns of both parents and HCPs to pave the way forward toward policy-making for DBS bio-banking and extended genetic testing in Hong Kong.

2.
J Trop Pediatr ; 64(5): 418-425, 2018 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-29106671

RESUMEN

AIM: To evaluate the cost-effectiveness of palivizumab prophylaxis for premature infants born <29 weeks in Hong Kong. METHOD: We evaluated the hospitalization rate for respiratory syncytial virus (RSV) infection within the first 12 months of discharge of a cohort of preterm infants born between 2010 and 2014 at two local hospitals. RESULTS: In total, 40 of 135 infants were given palivizumab. The hospitalization rate for premature infants <29 weeks was reduced from 15.8 to 5% (p = 0.096) and that for infants <27 weeks was reduced from 33.3 to 8.7% (p = 0.046). In the former group, the incremental cost-effectiveness ratio per hospital admission prevented (ICER/HAP) was US dollar (USD) 24 365. In the latter subgroup, the ICER/HAP was USD 3108. CONCLUSION: The cost-effectiveness as measured for infants <27 weeks is more favorable than that for infants <29 weeks.


Asunto(s)
Anticuerpos Monoclonales/economía , Antivirales/farmacología , Costos de los Medicamentos/estadística & datos numéricos , Hospitalización/estadística & datos numéricos , Inmunoglobulinas Intravenosas/economía , Palivizumab/uso terapéutico , Infecciones por Virus Sincitial Respiratorio/economía , Infecciones por Virus Sincitial Respiratorio/prevención & control , Virus Sincitiales Respiratorios/inmunología , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Antivirales/administración & dosificación , Antivirales/uso terapéutico , Estudios de Cohortes , Costo de Enfermedad , Análisis Costo-Beneficio , Femenino , Edad Gestacional , Hong Kong , Hospitalización/economía , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Recién Nacido , Recien Nacido Prematuro , Unidades de Cuidados Intensivos/estadística & datos numéricos , Tiempo de Internación , Palivizumab/economía , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitiales Respiratorios/efectos de los fármacos , Estaciones del Año , Resultado del Tratamiento
3.
AJP Rep ; 7(2): e101-e105, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28515969

RESUMEN

In the treatment of left-sided pulmonary interstitial emphysema (PIE) in a 23-week neonate, we used two ventilatory strategies: selective bronchial intubation from day 10 to 15 and neurally adjusted ventilatory assist (NAVA) from day 18 to 26. We compared the effects and adverse effects of these two strategies. On selective bronchial intubation, desaturation was frequent. Fentanyl infusion was required. There was an episode of carbon dioxide retention coupled with hypotension. On NAVA, the neonate was clinically stable without the requirement of sedation. On selective bronchial intubation, ventilator setting in terms of mean airway pressure and oxygen requirement was higher, which came down on the first day of NAVA. Radiologically unilateral PIE did not resolve and became localized in the left middle zone of lung field on selective bronchial intubation. Also, the lobar collapse of ipsilateral, as well as contralateral lungs occurred. On NAVA, unilateral PIE resolved. NAVA might be a good option for the management of unilateral PIE.

5.
J Matern Fetal Neonatal Med ; 25(4): 364-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21609204

RESUMEN

OBJECTIVE: The objective of this study was to evaluate the relationship between histological chorioamnionitis and laboratory markers of infection and congenital sepsis in very-low-birth-weight (VLBW) premature neonates. METHOD: This study is a retrospective review of laboratory results of VLBW neonates with birth weight less than 1500 g in our neonatal intensive care unit (NICU) in the last 5 years. RESULTS: Ninety-nine VLBW neonates had histological chorioamnionitis, and 50 of them further had funisitis. One hundred and sixty-two VLBW neonates did not have chorioamnionitis. The chorioamnionitis group was more likely than the 'no chorioamnionitis' group to have raised C-reactive proteins (23% versus 9.9%; p = 0.006) and neutrophilia (41% versus 4.3%; p < 0.001). White blood cells were more likely to be present in gastric lavage of the former group than the latter group (70% versus 50%; p = 0.002). Ear swab and gastric lavage were more likely to yield positive growth of micro-organisms from the former group than the latter group (34% versus 9.9% and 22% versus 2.7%; p < 0.001 and p < 0.001, respectively). Congenital sepsis proven by positive blood culture was also more likely to occur (3% versus 0%; p = 0.027). Presence of funisitis further increased the likelihood of the above abnormal laboratory results. CONCLUSIONS: Histological chorioamnionitis increases the likelihood of having markers of infection, bacterial colonization, and congenital sepsis. Only 3% of histological chorioamnionitis resulted in congenital sepsis confirmed by blood culture.


Asunto(s)
Fenómenos Fisiológicos Bacterianos , Biomarcadores/análisis , Corioamnionitis/diagnóstico , Corioamnionitis/microbiología , Recién Nacido de muy Bajo Peso , Sepsis/diagnóstico , Edad de Inicio , Corioamnionitis/patología , Técnicas de Laboratorio Clínico/métodos , Femenino , Humanos , Recién Nacido , Enfermedades del Recién Nacido/diagnóstico , Enfermedades del Recién Nacido/microbiología , Enfermedades del Prematuro/diagnóstico , Enfermedades del Prematuro/microbiología , Recién Nacido de muy Bajo Peso/inmunología , Recién Nacido de muy Bajo Peso/fisiología , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/microbiología , Complicaciones Infecciosas del Embarazo/patología , Estudios Retrospectivos , Sepsis/congénito , Sepsis/epidemiología , Sepsis/microbiología
6.
J Matern Fetal Neonatal Med ; 22(8): 711-3, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19521930

RESUMEN

We report a case of survival of homozygous alpha-thalassemia with aplasia/hypoplasia of phalanges and jejunal atresia. The occurrence of these malformations is consistent with the postulation that intra-uterine hypoxia due to the presence of hemoglobin Bart's (Hb Bart's) is the causative factor for the development of these malformations. There were two pitfalls in diagnosis: normal spun hematocrit level despite a low hemoglobin level and absence of hydropic features. Our case illustrated that nitric oxide and high frequency ventilation were ineffective in ameliorating persistent pulmonary hypertension of newborn until exchange transfusion was done replacing Hb Bart's with normal hemoglobin.


Asunto(s)
Falanges de los Dedos de la Mano/anomalías , Atresia Intestinal/complicaciones , Yeyuno/anomalías , Falanges de los Dedos del Pie/anomalías , Talasemia alfa/diagnóstico , Talasemia alfa/terapia , Recambio Total de Sangre , Femenino , Hematócrito , Hemoglobinas/análisis , Hemoglobinas Anormales/efectos adversos , Ventilación de Alta Frecuencia , Homocigoto , Humanos , Recién Nacido , Óxido Nítrico/administración & dosificación , Síndrome de Circulación Fetal Persistente/complicaciones , Síndrome de Circulación Fetal Persistente/terapia , Embarazo , Talasemia alfa/complicaciones
7.
Ann Trop Paediatr ; 24(2): 179-83, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15186548

RESUMEN

We investigated whether premature, very low-birthweight (VLBW) Asian children without major handicap had poor motor skills compared with their normal birthweight counterparts. We compared a cohort of 42 preterm babies with birthweights <1500 g who participated in a developmental stimulation programme with 69 children of normal birthweight matched for age, gender and paternal education. VLBW children participated in the programme for 3 years and were followed to the age of 5-7 years. The VLBW cohort had significantly lower scores in B- and C-rated skills of the Peabody Developmental Motor Scales. Their total score was also significantly lower. This is in agreement with studies in other populations that found that VLBW children had lower motor scores and that early interventions failed to ameliorate this motor disadvantage.


Asunto(s)
Recien Nacido Prematuro/psicología , Recién Nacido de muy Bajo Peso/psicología , Destreza Motora , Constitución Corporal , Estudios de Casos y Controles , Niño , Preescolar , Discapacidades del Desarrollo/epidemiología , Femenino , Hong Kong/epidemiología , Humanos , Recién Nacido , Masculino , Estudios Retrospectivos , Estadísticas no Paramétricas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...